MedKoo Cat#: 526318 | Name: Sch 47896

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Sch 47896 is a neutral metalloendopeptidase (NEP) inhibitor.

Chemical Structure

Sch 47896
Sch 47896
CAS#142621-29-2

Theoretical Analysis

MedKoo Cat#: 526318

Name: Sch 47896

CAS#: 142621-29-2

Chemical Formula: C22H26N2O7

Exact Mass: 430.1740

Molecular Weight: 430.46

Elemental Analysis: C, 61.39; H, 6.09; N, 6.51; O, 26.02

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Sch 47896; Sch47896; Sch-47896.
IUPAC/Chemical Name
beta-Alanine, N-(N-(1-carboxy-3-(4-hydroxyphenyl)propyl)-L-phenylalanyl)-2-hydroxy-, (S-(R*,R*))-
InChi Key
InChi Code
SMILES Code
O=C(O)C[C@H](O)NC([C@H](CC1=CC=CC=C1)N[C@H](C(O)=O)CCC2=CC=C(O)C=C2)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 430.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Jandeleit-Dahm K, Burrell LM, Kanazawa M, Casley D, Jackson B, Johnston CI. Effects of neutral endopeptidase inhibition in the rat remnant kidney model. Kidney Blood Press Res. 1998;21(6):419-24. PubMed PMID: 9933826. 2: Yoshida K, Kanazawa M, Casley DJ, Katopothis A, Johnston CI. Inhibition of kidney neutral endopeptidase after administration of the neutral endopeptidase inhibitor candoxatril: quantitation by autoradiography. J Cardiovasc Pharmacol. 1998 Nov;32(5):702-8. PubMed PMID: 9821842. 3: Kanazawa M, Yasujima M, Kohzuki M, Abe K. [Activity and localization of neutral metalloendopeptidase (EC 3.4.24.11) (NEP), the degradative enzyme for atrial natriuretic peptide (ANP), in rat kidney]. Nihon Jinzo Gakkai Shi. 1994 Jul;36(7):791-9. Japanese. PubMed PMID: 8072216. 4: Kanazawa M, Casley DJ, Sybertz EJ, Haslanger MF, Johnston CI. Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor. J Pharmacol Exp Ther. 1992 Jun;261(3):1231-7. PubMed PMID: 1534841.